Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its boronic acid functional group enables participation in Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing carbon-carbon bonds. Commonly employed in research settings to design enzyme inhibitors, especially targeting serine proteases involved in disease pathways. Also utilized in the preparation of boron-containing compounds for potential use in neutron capture therapy and molecular imaging.